Introduction: One of the emerging problems is that the percentage of azole-resistant A.
Aims: To test the hypothesis that treatment outcome is poorer in CPA patients with azole-resistant A.fumigatus than in those with azole-sensitive.
Materials and Methods: We retrospectively reviewed medical records of 64 CPA patients with isolation of A.
Results: There were 4 itraconazole (ITCZ) resistant isolates (5.3%) and 2 voriconazole (VRCZ) resistant isolates (2.7%). The 2 VRCZ resistant strains were also resistant to ITCZ. Three of 4
Conclusion: This study suggests CPA by azole resistance A.fumigatus have poor treatment outcome with azole antifungal treatment.
Full conference title:
- ERS 26th (2016)